Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-09

FDA Approved: AMETHYST — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for AMETHYST (levonorgestrel and ethinyl estradiol) submitted by Teva Pharmaceuticals, Inc. The supplemental action typi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMETHYST (LEVONORGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for AMETHYST (LEVONORGESTREL AND ETHINYL ESTRADIOL)